Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system.
about
Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition.Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.Quantification of clonal circulating plasma cells in relapsed multiple myeloma54-year-old woman with fatigue, back pain, and hypercalcemiaFlow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases.How best to use new therapies in multiple myeloma.Management of high-risk Myeloma: an evidence-based review of treatment strategies.Standardisation of minimal residual disease in multiple myeloma.Prognostic value of circulating plasma cells in patients with multiple myeloma: A meta-analysis.Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era.Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation.Assessment of minimal residual disease in myeloma and the need for a consensus approach.Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation methodCirculating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics.Multiple primary cutaneous plasmacytoma a decade after a nasal solitary extramedullary plasmacytoma: a puzzling case.Current applications of multiparameter flow cytometry in plasma cell disorders.Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry.In vivo and in silico studies on single versus multiple transplants for multiple myeloma.Mobilization policy in multiple myeloma: minimum target or law of redundancy? Two different approaches by the two sides of the Atlantic Ocean.Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma.Detection and Characterization of Circulating Tumour Cells in Multiple Myeloma.Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)
P2860
Q30938779-0A8B711B-728D-4342-86DB-DBE61744FD77Q34173892-B0D3B61D-25D4-4FAD-8689-5C9B7BC142F6Q34416126-FFD48532-5AE4-4776-A789-DF4A8CF4D97EQ37454464-F9FD69AF-8E76-48D0-9E34-975183F02693Q37626783-5575E5E3-EDBA-4C55-8F4C-A94EA7CF4AC6Q37723000-524D4F38-24D7-4E3D-9717-B88E0BD4DEE6Q38874675-30BE2CC4-093F-40F0-A2DC-AD723EF17C11Q39410899-55CFD6AC-9F8E-4D92-8803-4DFCCABDADABQ41007930-051C1FCD-21AF-4CBE-B8F0-7A20C36E552DQ41091821-50162EAE-799D-44CC-967F-ED9D8FBD38DDQ41230421-A26EC079-9248-4C90-AB6A-A1B103BDF462Q41556524-4A34E091-AE3F-4B7A-AF5D-073FCB9C0969Q41557109-0BA958CB-5B51-43BF-8A41-CE0DFCE6FE75Q41717875-1827A30A-6C67-43A7-AA8A-3A0D95D95869Q42359833-FC73CAE5-514D-4EA3-BC5C-95FE28C87C7CQ47110039-46796AC2-4618-436B-92CD-4E681A991DFAQ49641900-379CAE6D-D6DE-4E52-8F24-25655EE2B0E4Q51919960-57CE7A65-060B-46A2-B90B-214F4F0B3F96Q53922357-87CA4AB0-87FA-429C-92B6-FC4F0FE62651Q54562253-ABF070CF-212C-4B2A-8407-C952F8629E71Q55208548-C0B34DF1-5A4B-4109-938A-C6E44864FC02Q59135626-3837C4F0-C71B-47EC-9956-CF7E96C6FB05
P2860
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Flow cytometric detection of c ...... le risk stratification system.
@ast
Flow cytometric detection of c ...... le risk stratification system.
@en
type
label
Flow cytometric detection of c ...... le risk stratification system.
@ast
Flow cytometric detection of c ...... le risk stratification system.
@en
prefLabel
Flow cytometric detection of c ...... le risk stratification system.
@ast
Flow cytometric detection of c ...... le risk stratification system.
@en
P2093
P2860
P50
P1433
P1476
Flow cytometric detection of c ...... le risk stratification system.
@en
P2093
Dennis A Gastineau
Grzegorz S Nowakowski
Mark R Litzow
Philip R Greipp
Thomas E Witzig
P2860
P304
P356
10.1182/BLOOD-2005-08-3398
P407
P577
2005-12-08T00:00:00Z